Gestational diabetes mellitus(GDM)is one of the most common metabolic disorders of pregnancy and can cause short-and long-term adverse effects in both pregnant women and their offspring.However,the etiology and pathog...Gestational diabetes mellitus(GDM)is one of the most common metabolic disorders of pregnancy and can cause short-and long-term adverse effects in both pregnant women and their offspring.However,the etiology and pathogenesis of GDM are still unclear.As a metabolic disease,GDM is well suited to metabolomics study,which can monitor the changes in small molecular metabolites induced by maternal stimuli or perturbations in real time.The application of metabolomics in GDM can be used to discover diagnostic biomarkers,evaluate the prognosis of the disease,guide the application of diet or drugs,evaluate the curative effect,and explore the mechanism.This review provides comprehensive documentation of metabolomics research methods and techniques as well as the current progress in GDM research.We anticipate that the review will contribute to identifying gaps in the current knowledge or metabolomics technology,provide evidence-based information,and inform future research directions in GDM.展开更多
BACKGROUND The birth of large-for-gestational-age(LGA)infants is associated with many shortterm adverse pregnancy outcomes.It has been observed that the proportion of LGA infants born to pregnant women with gestationa...BACKGROUND The birth of large-for-gestational-age(LGA)infants is associated with many shortterm adverse pregnancy outcomes.It has been observed that the proportion of LGA infants born to pregnant women with gestational diabetes mellitus(GDM)is significantly higher than that born to healthy pregnant women.However,traditional methods for the diagnosis of LGA have limitations.Therefore,this study aims to establish a predictive model that can effectively identify women with GDM who are at risk of delivering LGA infants.AIM To develop and validate a nomogram prediction model of delivering LGA infants among pregnant women with GDM,and provide strategies for the effective prevention and timely intervention of LGA.METHODS The multivariable prediction model was developed by carrying out the following steps.First,the variables that were associated with LGA risk in pregnant women with GDM were screened by univariate analyses,for which the P value was<0.10.Subsequently,Least Absolute Shrinkage and Selection Operator regression was fit using ten cross-validations,and the optimal combination factors were se-lected by choosing lambda 1se as the criterion.The final predictors were deter-mined by multiple backward stepwise logistic regression analysis,in which only the independent variables were associated with LGA risk,with a P value<0.05.Finally,a risk prediction model was established and subsequently evaluated by using area under the receiver operating characteristic curve,calibration curve and decision curve analyses.RESULTS After using a multistep screening method,we establish a predictive model.Several risk factors for delivering an LGA infant were identified(P<0.01),including weight gain during pregnancy,parity,triglyceride-glucose index,free tetraiodothyronine level,abdominal circumference,alanine transaminase-aspartate aminotransferase ratio and weight at 24 gestational weeks.The nomogram’s prediction ability was supported by the area under the curve(0.703,0.709,and 0.699 for the training cohort,validation cohort,and test cohort,respectively).The calibration curves of the three cohorts displayed good agreement.The decision curve showed that the use of the 10%-60%threshold for identifying pregnant women with GDM who are at risk of delivering an LGA infant would result in a positive net benefit.CONCLUSION Our nomogram incorporated easily accessible risk factors,facilitating individualized prediction of pregnant women with GDM who are likely to deliver an LGA infant.展开更多
基金Supported by the National Natural Science Foundation of China,No.81870546the Nanjing Medical Science and Technique Development Foundation,No.YKK17177.
文摘Gestational diabetes mellitus(GDM)is one of the most common metabolic disorders of pregnancy and can cause short-and long-term adverse effects in both pregnant women and their offspring.However,the etiology and pathogenesis of GDM are still unclear.As a metabolic disease,GDM is well suited to metabolomics study,which can monitor the changes in small molecular metabolites induced by maternal stimuli or perturbations in real time.The application of metabolomics in GDM can be used to discover diagnostic biomarkers,evaluate the prognosis of the disease,guide the application of diet or drugs,evaluate the curative effect,and explore the mechanism.This review provides comprehensive documentation of metabolomics research methods and techniques as well as the current progress in GDM research.We anticipate that the review will contribute to identifying gaps in the current knowledge or metabolomics technology,provide evidence-based information,and inform future research directions in GDM.
基金Supported by National Natural Science Foundation of China,No.81870546Nanjing Medical Science and Technique Development Foundation,No.YKK23151Science and Technology Development Foundation Item of Nanjing Medical University,No.NMUB20210117.
文摘BACKGROUND The birth of large-for-gestational-age(LGA)infants is associated with many shortterm adverse pregnancy outcomes.It has been observed that the proportion of LGA infants born to pregnant women with gestational diabetes mellitus(GDM)is significantly higher than that born to healthy pregnant women.However,traditional methods for the diagnosis of LGA have limitations.Therefore,this study aims to establish a predictive model that can effectively identify women with GDM who are at risk of delivering LGA infants.AIM To develop and validate a nomogram prediction model of delivering LGA infants among pregnant women with GDM,and provide strategies for the effective prevention and timely intervention of LGA.METHODS The multivariable prediction model was developed by carrying out the following steps.First,the variables that were associated with LGA risk in pregnant women with GDM were screened by univariate analyses,for which the P value was<0.10.Subsequently,Least Absolute Shrinkage and Selection Operator regression was fit using ten cross-validations,and the optimal combination factors were se-lected by choosing lambda 1se as the criterion.The final predictors were deter-mined by multiple backward stepwise logistic regression analysis,in which only the independent variables were associated with LGA risk,with a P value<0.05.Finally,a risk prediction model was established and subsequently evaluated by using area under the receiver operating characteristic curve,calibration curve and decision curve analyses.RESULTS After using a multistep screening method,we establish a predictive model.Several risk factors for delivering an LGA infant were identified(P<0.01),including weight gain during pregnancy,parity,triglyceride-glucose index,free tetraiodothyronine level,abdominal circumference,alanine transaminase-aspartate aminotransferase ratio and weight at 24 gestational weeks.The nomogram’s prediction ability was supported by the area under the curve(0.703,0.709,and 0.699 for the training cohort,validation cohort,and test cohort,respectively).The calibration curves of the three cohorts displayed good agreement.The decision curve showed that the use of the 10%-60%threshold for identifying pregnant women with GDM who are at risk of delivering an LGA infant would result in a positive net benefit.CONCLUSION Our nomogram incorporated easily accessible risk factors,facilitating individualized prediction of pregnant women with GDM who are likely to deliver an LGA infant.